Keywords: Osteologix, NB S101, Osteoporosis, Research, Servier, Protelos

Osteologix continues development of NB S101 for osteoporosis

Article | 21 October 2009

Print This

Marking its own progress and in recognition of World Osteoporosis Day, USA-based Osteologix says it will continue the clinical development ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in